ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,377, issued on Oct. 7, was assigned to THE BROAD INSTITUTE INC. (Cambridge, Mass.), DANA-FARBER CANCER INSTITUTE INC. (Boston) and INSTITUTO CARLOS SLIM DE LA SALUD A.C (Mexico).

"Cancers with loss of chromosome 16Q and/or low expression of metallothionein proteins" was invented by Steven Corsello (Boston), Ryan Spangler (Cambridge, Mass.), Rohith Nagari (Cambridge, Mass.) and Todd Golub (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of cancers, particularly cancers that exhibit arm-level loss of chromosome 16q, focal copy loss o...